President and CEO
Scott Melville is the president and chief executive officer of the Consumer Healthcare Products Association (CHPA) and leads the organization’s efforts to empower consumer self-care by preserving and expanding choice and availability of consumer healthcare products.
With a diverse background in pharmaceuticals, association management, public policy and law, Melville has advocated before Congress, the U.S. Food and Drug Administration, state legislative and regulatory bodies, and the media. Prior to joining CHPA, Melville served as senior vice president for government affairs and general counsel for the Healthcare Distribution Management Association, the national association representing pharmaceutical wholesale distributors, where he was responsible for federal and state legislative, regulatory, legal, and political affairs. Previously, Melville served as an attorney and head of government relations for Cephalon, Inc., an international biopharmaceutical company, since acquired by TEVA Pharmaceuticals, and in public policy and government affairs positions at Hoffmann-La Roche and Sterling Winthrop, Inc. He is a former chair of the Pennsylvania Biotechnology Association. Prior to joining the pharmaceutical industry, Melville served as legislative counsel and Appropriations Committee associate on the staff of retired U.S. Congressman Jerry Lewis (R-Calif.).
Melville earned his bachelor’s degree from Bucknell University, and his juris doctorate from George Mason University School of Law. He serves on the boards of the World Self-Medication Industry association, the CHPA Educational Foundation, and the Food & Drug Law Institute.
Education: B.A., Bucknell University
J.D., George Mason University School of Law